학술논문
Real-life experience after 3 months with tezepelumab before marketing approval
Document Type
Article
Author
Source
In: Allergologia et Immunopathologia . (Allergologia et Immunopathologia, 2024, 52(2):80-82)
Subject
Language
English
ISSN
15781267
03010546
03010546